Table of contents
February 2004 Vol 4 No 2
In this issue
p87 | doi:10.1038/nrc1287
Research Highlights
Tumour immunity: Throwing LIGHT on tumour rejection
p89 | doi:10.1038/nrc1292
Metastasis: CAV1 connection
p90 | doi:10.1038/nrc1283
Therapeutics: All exits blocked
p90 | doi:10.1038/nrc1285
In the news
To eat, or not to eat
p90 | doi:10.1038/nrc1291
In brief
Chromosome instability | Metastasis | Gene expression | Gene therapy
p91 | doi:10.1038/nrc1290
Tumour suppressor: Garbage disposal
p92 | doi:10.1038/nrc1280
Tumour suppressors: The protective effect of arrest
p92 | doi:10.1038/nrc1284
Tumour suppressors: BRCA2: preventing a breakdown
p93 | doi:10.1038/nrc1282
Metastasis: A key to metastasis
p94 | doi:10.1038/nrc1288
Therapeutics: Unleashing p53
p94 | doi:10.1038/nrc1293
Imaging: Finding your way
p95 | doi:10.1038/nrc1281
Trial Watch
Natural born killers | Obesity and prostate cancer
p95 | doi:10.1038/nrc1294
Reviews
The STATs of cancer — new molecular targets come of age
Hua Yu & Richard Jove
p97 | doi:10.1038/nrc1275
Nuclear transport and cancer: from mechanism to intervention
Tweeny R. Kau, Jeffrey C. Way & Pamela A. Silver
p106 | doi:10.1038/nrc1274
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Ugo Cavallaro & Gerhard Christofori
p118 | doi:10.1038/nrc1276
The SWI/SNF complex — chromatin and cancer
Charles W. M. Roberts & Stuart H. Orkin
p133 | doi:10.1038/nrc1273
Perspectives
Timeline
The history of cancer epigenetics
Andrew P. Feinberg & Benjamin Tycko
p143 | doi:10.1038/nrc1279
Guidelines
Testing guidelines for hereditary non-polyposis colorectal cancer
Asad Umar, John I. Risinger, Ernest T. Hawk & J. Carl Barrett
p153 | doi:10.1038/nrc1278
Opinion
Radiation-induced bystander effects — implications for cancer
Colin B. Seymour & Carmel Mothersill
p158 | doi:10.1038/nrc1277
